Crosstalk between sIgA-Coated Bacteria in Infant Gut and Early-Life Health.

Gut microbiota transmission from mother to offspring has attracted much interest in recent years. The gut microbiota in the infant plays a potentially significant role in modulating and maintaining the development of infant immunity. Secretory immunoglobulin A (sIgA), the major immunoglobulin in the intestine, can target polysaccharides and flagellin on the bacterial surface, resulting in sIgA-coated bacteria. The presentation of specific bacteria coated with sIgA may be a signal of disease and provide novel insights into the relationship between infant microbiota and disease. Here, we review the composition of sIgA-coated bacteria in the adult intestine, human milk, and the infant intestine, as well as the factors that influence the development of gut microbiota in early life. Then, we highlight the diseases that are related to variations in sIgA-coated bacteria in the infant and adult intestine. Furthermore, we discuss the possibility that sIgA-coated bacteria could play a role in mediating both innate and adaptive immune responses. Finally, we propose directions for future research to promote our understanding within this field. Secretory immunoglobulin A (sIgA)-coated bacteria in the intestine exhibit different profiles dependent on the age and diet of the host and no core composition has been identified due to the fact that members of the same species can exist in two different forms (sIgA+ and sIgA–). sIgA-coated bacteria may translocate from the maternal intestine to human milk. The infant gut exhibits a time-dependent sIgA-coated bacterial composition, and factors such as genetics, feeding method, zygosity, and delivery mode influence this composition. The alteration of sIgA-coated bacteria may indicate the occurrence of disease within the newborn period. sIgA-coated bacteria modulate the immune system (both innate immunity and adaptive immunity) via unique modes. [ABSTRACT FROM AUTHOR]